These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 1423431)

  • 1. Reactive and reparative myocardial fibrosis in arterial hypertension in the rat.
    Brilla CG; Weber KT
    Cardiovasc Res; 1992 Jul; 26(7):671-7. PubMed ID: 1423431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-aldosterone treatment and the prevention of myocardial fibrosis in primary and secondary hyperaldosteronism.
    Brilla CG; Matsubara LS; Weber KT
    J Mol Cell Cardiol; 1993 May; 25(5):563-75. PubMed ID: 8377216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aldosterone and myocardial fibrosis in heart failure.
    Brilla CG
    Herz; 2000 May; 25(3):299-306. PubMed ID: 10904856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antifibrotic effects of spironolactone in preventing myocardial fibrosis in systemic arterial hypertension.
    Brilla CG; Matsubara LS; Weber KT
    Am J Cardiol; 1993 Jan; 71(3):12A-16A. PubMed ID: 8421998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Remodeling of the rat right and left ventricles in experimental hypertension.
    Brilla CG; Pick R; Tan LB; Janicki JS; Weber KT
    Circ Res; 1990 Dec; 67(6):1355-64. PubMed ID: 1700933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aldosterone antagonist facilitates the cardioprotective effects of angiotensin receptor blockers in hypertensive rats.
    Tanabe A; Naruse M; Hara Y; Sato A; Tsuchiya K; Nishikawa T; Imaki T; Takano K
    J Hypertens; 2004 May; 22(5):1017-23. PubMed ID: 15097243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Left ventricular fibrosis in renovascular hypertensive rats. Effect of losartan and spironolactone.
    Nicoletti A; Heudes D; Hinglais N; Appay MD; Philippe M; Sassy-Prigent C; Bariety J; Michel JB
    Hypertension; 1995 Jul; 26(1):101-11. PubMed ID: 7607712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Spironolactone: renaissance of anti-aldosterone therapy in heart failure?].
    Brilla CG; Schencking M; Scheer C; Rupp H
    Praxis (Bern 1994); 1997 Apr; 86(14):566-74. PubMed ID: 9198851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regression of myocardial fibrosis in hypertensive heart disease: diverse effects of various antihypertensive drugs.
    Brilla CG
    Cardiovasc Res; 2000 May; 46(2):324-31. PubMed ID: 10773237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reactive and reparative fibrillar collagen remodelling in the hypertrophied rat left ventricle: two experimental models of myocardial fibrosis.
    Silver MA; Pick R; Brilla CG; Jalil JE; Janicki JS; Weber KT
    Cardiovasc Res; 1990 Sep; 24(9):741-7. PubMed ID: 2146020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of high salt diet-induced cardiac hypertrophy and fibrosis by spironolactone.
    Lal A; Veinot JP; Leenen FH
    Am J Hypertens; 2003 Apr; 16(4):319-23. PubMed ID: 12670750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of aldosterone in angiotensin II-induced cardiac and aortic inflammation, fibrosis, and hypertrophy.
    Neves MF; Amiri F; Virdis A; Diep QN; Schiffrin EL;
    Can J Physiol Pharmacol; 2005 Nov; 83(11):999-1006. PubMed ID: 16391708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mineralocorticoid excess, dietary sodium, and myocardial fibrosis.
    Brilla CG; Weber KT
    J Lab Clin Med; 1992 Dec; 120(6):893-901. PubMed ID: 1453111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myocardial fibrosis in the rat with mineralocorticoid excess. Prevention of scarring by amiloride.
    Campbell SE; Janicki JS; Matsubara BB; Weber KT
    Am J Hypertens; 1993 Jun; 6(6 Pt 1):487-95. PubMed ID: 8343231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Collagen metabolism in cultured adult rat cardiac fibroblasts: response to angiotensin II and aldosterone.
    Brilla CG; Zhou G; Matsubara L; Weber KT
    J Mol Cell Cardiol; 1994 Jul; 26(7):809-20. PubMed ID: 7966349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myocardial fibrosis associated with aldosterone or angiotensin II administration: attenuation by calcium channel blockade.
    Ramires FJ; Sun Y; Weber KT
    J Mol Cell Cardiol; 1998 Mar; 30(3):475-83. PubMed ID: 9515025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myocardial fibrosis: role of ventricular systolic pressure, arterial hypertension, and circulating hormones.
    Weber KT; Brilla CG; Janicki JS; Reddy HK; Campbell SE
    Basic Res Cardiol; 1991; 86 Suppl 3():25-31. PubMed ID: 1781767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aldosterone-induced inflammation in the rat heart : role of oxidative stress.
    Sun Y; Zhang J; Lu L; Chen SS; Quinn MT; Weber KT
    Am J Pathol; 2002 Nov; 161(5):1773-81. PubMed ID: 12414524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Telmisartan predominantly suppresses cardiac fibrosis, rather than hypertrophy, in renovascular hypertensive rats.
    Kawai M; Hongo K; Komukai K; Morimoto S; Nagai M; Seki S; Taniguchi I; Mochizuki S; Yoshimura M
    Hypertens Res; 2009 Jul; 32(7):604-10. PubMed ID: 19424279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Steroidogenic acute regulatory protein/aldosterone synthase mediates angiotensin II-induced cardiac fibrosis and hypertrophy.
    Zhang WW; Zheng RH; Bai F; Sturdivant K; Wang NP; James EA; Bose HS; Zhao ZQ
    Mol Biol Rep; 2020 Feb; 47(2):1207-1222. PubMed ID: 31820314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.